This forum will discuss the research and application of personalized reproductive medicine from the perspective of precision medicine. A total of 8 physicians and experts from 5 countries are invited to share their clinical experience and academic viewpoints, and to bring new light to reproductive medicine.
The development of Pre-implantation Genetic Testing for Aneuploidy (PGT-A) has helped many infertility patients to successfully conceive. However, there are still many management consideration and pondering points after this test. For example, what is the next step after implantation of mosaic embryos? Is it still possible for the fetus to have uniparental disomy (UPD) or microdeletions? Should Non-Invasive Prenatal Testing (NIPT) or amniotic fluid microarray be considered even after PGT-A? Which one?
MicroRNA has been the up-and-coming new trend in test development encompassing much hope and potential. Its research and application in the field of reproductive medicine is booming and maturing. In particular, the advantages of utilizing microRNA in endometrial receptivity analysis for clinical management is emerging. Speakers in this session will cover diverse aspects surrounding microRNA, including academic research, clinical experience, and future development.
We sincerely invite you to join in this grand event!
Time: 09:00 am – 12:00 pm (UCT+8)
Organizer: GGA Corp.